Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected developing COVID-19. Since the beginning of the pandemic in …

With the onset of the COVID-19 pandemic, it became apparent that, in addition to pulmonary
infection, extrapulmonary manifestations such as cardiac injury and acute cerebrovascular …

Currently, the COVID-19 pandemic is an international challenge, largely due to lack of
effective therapies. Pharmacotherapy has not yet been able to find a definitive treatment for …

Renin-angiotensin system (RAS) modulators, including Angiotensin receptor blockers (ARB)
and angiotensin-converting enzyme inhibitors (ACEI), are effective medications for …

Objective Investigations on coagulation parameters including fibrinogen (Fbg), fibrinogen
degradation products (FDP), and D-dimer in ischemic stroke patients treated with …

Background Studies during the COVID-19 pandemic have demonstrated an association
between COVID-19 virus infection and the development of acute ischemic stroke …

Background Acute ischemic stroke (AIS) is a common complication of severe acute
respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection (COVID-19), but the prognosis …

Background The pandemic of COVID-19 has had a profound influence on worldwide
healthcare systems. Our study aimed to conduct a bibliometric analysis to explore the impact …

Objective This study aims to investigate the impact of the infection with the novel coronavirus
Omicron variant on the outcomes of patients with severe spontaneous intracerebral …

Background Neurological manifestations of COVID-19 are thought to be associated with the
disease severity of COVID-19 and poor clinical outcomes. Dysregulated immune responses …